ClinicalTrials.Veeva

Menu

Therapeutic Exposures and Risk Factors in MRONJ

M

Marmara University

Status

Enrolling

Conditions

Medication-Related Osteonecrosis of Jaw

Study type

Observational

Funder types

Other

Identifiers

NCT06430762
CIBON-MAR-A.1

Details and patient eligibility

About

This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 110 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals aged 18 and over
  • Male or female individuals
  • Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
  • Individuals or their legal representatives who have given written consent to participate in the study

Exclusion criteria

  • Non-drug-related osteonecrosis/osteomyelitis
  • Osteoradionecrosis
  • Metastasis to the oral region
  • Individuals who have not given written consent to participate in the study
  • Individuals under the age of 18

Trial contacts and locations

1

Loading...

Central trial contact

Ferit Bayram, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems